Most cellular processes are driven by simple biochemical mechanisms such as protein and lipid phosphorylation, but the sum of all these conversions is exceedingly complex. Hence, intuition alone is not enough to discern the underlying mechanisms in the light of experimental data. Toward this end, mathematical models provide a conceptual and numerical framework to formally evaluate the plausibility of biochemical processes. To illustrate the use of these models, here we built a mechanistic computational model of PI3K (phosphatidylinositol 3-kinase) activity, to determine the kinetics of lipid metabolizing enzymes in single cells. The model is trained to data generated upon perturbation with a reversible small-molecule based chemical dimerization system that allows for the very rapid manipulation of the PIP 3 (phosphatidylinositol 3,4,5-trisphosphate) signaling pathway, and monitored with live-cell microscopy. We find that the rapid relaxation system used in this work decreased the uncertainty of estimating kinetic parameters compared to methods based on in vitro assays. We also examined the use of Bayesian parameter inference and how the use of such a probabilistic method gives information on the kinetics of PI3K and PTEN activity.
Introduction
In order to understand signaling networks and their role in the regulation of the cell as well as their deregulation in disease, it is necessary to be able to measure their constituents, such as proteins and their PTMs (Post Translational Modifications) and small molecules involved in signaling, at the single cell level and at multiple time points. There are now many experimental methods that are capable of such measurements. These include on the one hand fluorescent microscopy techniques such as FRET (Förster Resonance Energy Transfer) and FRAP (Fluorescence Recovery after Photobleaching) for live cells 27 and, on the other hand, more highthroughput techniques such as mass cytometry 8 that however destroy the cells during measurement. Such single cell measurements are important to understanding how signaling pathway dynamics can influence pathway output and ultimately the phenotype of the cell. Population-scale measurement techniques such as mass spectrometry or Western Blot can only attain average measurements over many cells. However, measuring single cell dynamics can uncover novel mechanisms that are not apparent from measuring at the population scale. For example, the occurrence of NFjB oscillations across cell populations 23 and the dynamic properties of certain signaling proteins (e.g., ERK; 3 and calcium 7 have only become apparent through single-cell measurement techniques. Another powerful approach to explore signaling is to monitor cells not just in their natural resting state, but upon perturbation of the activity of some of their components. Perturbation methods that artificially control intracellular enzymes have been developed using a variety of approaches. These include small molecule inhibitors, RNAi and multiple genomic methods, such as CRISPR genomeediting. One particularly powerful tool is chemical dimerization, where one is able to rapidly switch on and off enzyme activity non-invasively through rapid cell entry of small molecules. The resulting changes in signaling dynamics can then be tracked in live cells. 24 Hypothesis prediction and validation using single cell measurements usually need to be aided by mathematical modeling. In many cases, where the biochemistry of the system is known, sets of ordinary differential equations are constructed from the underlying chemical reactions in the system. What is defined as the system can range from a full signaling pathway 9 to a particular set of reactions. 18 Such models have been used for a range of purposes, such as quantifying and understanding the source of heterogeneity in apoptosis, 2 and defining feedback in signaling pathways. 14 More generally, such models may serve to formalize hypotheses and assumptions about the data and can also be used to predict novel Despite the advantages of constructing such physicochemical models to provide mechanistic insight, there are many difficulties to overcome in their formulation and validation before they can be considered useful tools. The interactions that make up the model (the model structure) are often unknown and, for physicochemical models, it is a non-trivial task to search systematically over all possible models that explain the data, although recently methods have begun to address this. 4 Once a model structure has been chosen, the parameters, such as initial conditions and rate constants, may be unknown and need to be estimated from the data. In the cases where this is necessary, such unknown parameters may not be identifiable given the data and model structure. 16 There are many methods of parameter optimization (e.g., simulating annealing, particle swarm, multiple shooting, etc.), with associated advantages and disadvantages. 30 Bayesian inference is one such method that is suited to smaller models and provides a framework to quantify parameter uncertainty and formally compare alternative models.
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Here we illustrate the application of these modeling methods to phosphoinositide signaling. We show, using the perturbation data obtained via chemical dimerization in Ref. 13 , how Bayesian inference methods can help with model choice and with quantifying the uncertainty of parameter estimates based on such data. A model describing PIP 3 homeostasis is introduced and we show that the in vivo kinetics of some of the enzymes controlling PIP 3 metabolism (PI3K and PTEN) are much faster than previous estimates from in vitro experiments suggested.
Results

Experimental data
The experimental data is described in detail in Feng et al. 13 Briefly, the chemical dimerization system consists of a reversible chemical dimerizer rCD1 that binds to two proteins simultaneously, SNAP-tag and FKBP. The covalently binding SNAP-tag protein is fused to a protein localized in the plasma membrane (Lck) and to a fluorescent tag to form the construct Lck-ECFP-SNAP f . The induction of phosphatidylinositol 3-kinase (PI3K) can be investigated by fusing the mRFP-FKBP construct (FKBP bound to a fluorescent tag) with the inter-Src homology 2 (iSH2) domain from p85. p85 is the regulatory subunit of PI3K. Hence, when rCD1 is transfected into the cell, it causes p85 translocation to the plasma membrane, as rCD1 binds to both Lck-ECFP-SNAPf and mRFP-FKBP-iSH2. Henceforth, we will refer to this complex as iSH2. p85 then binds with the endogenous catalytic subunit p110a, thus activating PI3K. 28 In addition to triggering PI3K activity in HeLa cells, the production of its product PI(3,4,5)P 3 (PIP 3 ), which PI3K converts from PIP 2 , is also measured over time. This is done by quantifying translocation of the pleckstrin homology (PH) domain of Akt fused to a fluorescent protein (EGFP-PH Akt , henceforth referred to as PH Akt ) to the plasma membrane. 13 We used two experiments based on the method above to estimate the parameters of a model of PIP 3 metabolism, presented in Ref. 13 . In the first one ( Fig. 1 (left) ), the ratio of plasma membrane to cytoplasmic fluorescence of PH Akt and iSH2 is followed over time. There are two perturbations in this experiment. The first is the addition of rCD1, the small molecule dimerizer that brings iSH2 to the plasma membrane thus activating PI3K. The second is the addition of FK506 40 min after stimulation, a competitive dimerizer with rCD1 that causes iSH2 to be removed from the PM, thus deactivating PI3K rapidly. As PIP 3 levels are high at this stage of the experiments, rapidly stopping the PIP 3 supply allows one to follow PIP 3 metabolism in a relaxation type of experiment in intact single cells. Hence, this experimental setup is useful to monitor the dynamics of activation and deactivation of PI3K, as well as PIP 3 levels and its downstream effectors.
The second experiment ( Fig. 1 (right) ), is similar to the first in that the chemical dimerizer and FK506 are used to activate and deactivate PI3K and, again, the ratio of plasma membrane to cytoplasmic fluorescence of PH Akt and iSH2 is followed over time. The difference in this experiment is that the measurements only started 27.5 min after rCD1 addition when it is assumed the system has reached a steady state. Also, the PTEN inhibitor H 2 O 2 was an added perturbation at 30 min post-rCD1 addition, that is, after 2.5 min of the recorded traces. Hence, this experiment aimed to study the effect of PTEN inhibition on an already steadily activated PI3K.
For each experiment, a number of technical replicates were performed (see Supplementary part 1 for the breakdown of the experiments), resulting in traces from 22 cells for experiment 1 and 17 cells from experiment 2. Some of the traces were of poor quality for the first experiment. Therefore 14/22 single-cell traces were used in further analysis (see Supplementary part 1).
Data normalization
A prerequisite for modeling is to have all data normalized in a way so that it can be jointly used. After the data was scaled across both experiments (see Supplementary part 1), the distribution of steady state values of PH Akt from experiment 1 was compared to the distribution of initial values from experiment 2. The steady state from experiment 1 was taken as the mean value of the 10 measurements before addition of the FKBP binder FK506. This data across all single cells should have the same distribution as the initial values from experiment 2, as in experiment 2 measurements commenced at a steady state post-rCD1 activation. As can be seen from Figure 2 , the distributions are not the same (t = À15.6, p <0.001; Fig. 2 ) but their range is similar. Subtracting the difference in mean values from the 2 distributions from the experiment 2 distribution matches the steady state distributions across the 2 experiments (t = À0.29, p = 0.77). Hence, this correction was used on the presumption that it corrected for a shift in overall fluorescence, that is, technical variation between the 2 experiments.
Parameter optimization
As mentioned in the introduction, there are a number of different approaches to identifying the parameters of physicochemical models and they can be divided into a number of categories. Often, concentrations of the constituent species can be measured using quantitative methods such as Western blot or mass spectrometry. It is more difficult to find accurate prior knowledge of reaction parameters (such as binding constants), as these are poorly represented in the literature and in vitro methods of estimating such values are limited models of what actually occurs in the cell. This is because the in vitro environment is relatively homogenous compared to the complexity (space, constituents, etc.), of the cell. This seems to be especially true for reactions happening on membranes as these are difficult to mimic in the test tube. Because of this, reaction parameters tend to be estimated indirectly (i.e., inferred) using available data, in particular the concentration changes of their substrates and products.
There are a set of methods that attempt to find a single (or multiple) set of parameter values that minimize the distance between the data and the model. These methods use advanced algorithms to efficiently and quickly identify these solutions. Even though they cannot guarantee to find the very best set of parameter values, in practice they have been shown to work well in finding the best or close to the best solutions. 6 Reporting not just one but multiple sets of parameters is essential as there is pervasive uncertainty on the estimates. This is due to various factors ranging from the unavoidable experimental noise, the technical limitations when measuring certain components, the need to measure proteins under different conditions, and fundamental constraints due to the nature of the models. 30 Hence, one can rarely rely on a single value.
A more exhaustive approach, but in turn more computationally expensive, is to estimate the probability distribution of the parameters. The probability distribution of a parameter assigns a probability to all possible values for that parameter in the model. Such distributions take into account experimental variation, that is, the uncertainty of the experiment measurements used for model validation, and model non-identifiability. Bayesian statistics provides an appropriate framework to perform these analyses. 21, 32, 12, 17 In this paper, we use Bayesian inference to estimate these parameter probability distributions. Such distributions are termed the posterior distributions in Bayesian terminology and are a product of the prior distribution (i.e., one's prior knowledge or belief of the parameter) and the likelihood of the parameters given the data. These distributions are impossible to find analytically for non-trivial biological models so they must be estimated through sampling. One such method for sampling is the Markov Chain Monte Carlo (MCMC) walk. MCMC is based on the premise that the number of visits during the walk to a particular point in the parameter space is proportional to the posterior probability. Hence, if the walk contains enough steps, it should build an estimate of the distribution that is close to the true posterior.
Parameter estimation for all models was performed using Bayesian inference. The Python package BayesSB was used, which samples the posterior distribution using a Markov Chain Monte Carlo (MCMC) walk and imposing a Metropolis-Hastings (MH) criterion, a condition that helps the exploration of the parameter space, at each step. 12 The methodology used is detailed in Box 1 of Ref.
12. The models were also built using the Python package PySB. 22 All scripts are available as Supplementary materials.
Modeling the data
Model detail
When building a model, the key biological processes that the measurements represent need to be taken into account. In this system, it was clear that the enzymes PI3K and PTEN needed to be included in a model of PIP 3 dynamics. However, we also wanted to test if there were additional biological mechanisms that needed to be included to fully explain the data. At the same time, we did not want to over-fit the data by attempting to model non-biological (technical) variation: a measurement is in general a function of the underlying biology and biological/technical noise. In most cases, one is trying to understand the underlying mechanism and/or quantify the biological noise, and therefore an estimate of the technical noise needs to be made. For the data in this study, it is clear that iSH2 is activating PI3K and hence is causative of the increase in PH Akt as a result of PI3K increasing PIP 3 at the PM. From the PH Akt single cell traces (Fig. 3A) , in addition to a general monotonic increase in the PM/cytoplasmic ratio, there is considerable variation or fluctuation at shorter time scales. While this is probably mostly noise, it is interesting to test whether any of this variation is biological in nature. This can be inspected by looking at the correlation in the iSH2 and PH Akt traces for each single cell and specifically asking the question: can the previous n measurements (at t À 1. . . t À n) of iSH2 and PH Akt explain PH Akt at time t better than PH Akt alone (at t À 1. . . t À n). One such formal test of this relationship is the Granger causality test. 15 For the 14 single-cell traces, we tested Granger causality up to the addition of FK506. The traces after this time point were not included as FK506 addition causes a strong causal link between iSH2 and PH Akt and would hence confound results; iSH2 is 'pulled' from the plasma membrane, which in turn affects PH Akt , that is, here the direction of causality is obvious at this time point. The value of n in the Granger causality test was defined by testing over a range of n and taking the value that lead to the maximum Granger causality as averaged over all traces (see Supplementary part 3). The result was n = 1, meaning that taking any previous time-points beyond the immediately previous one from iSH2/PH Akt did not improve the prediction of PH Akt at time t. Then, by randomizing each single-cell iSH2 trace (see Supplementary part 3), we tested whether the true iSH2 traces were any better at predicting PH Akt compared to randomized iSH2 traces across each single cell (n = 14). Figure 3B shows that this was not the case (t = À0.61, p = À0.55), which suggests that the variation among them is not mechanistically connected and training a model to fit this variation (which can be viewed as noise) would likely result in over-fitting.
Testing model structures
Two mechanistic models of PIP 3 metabolism were developed to investigate the rates of catalysis of the enzymes that control PIP 3 dynamics. Both were based on the general scheme where the conversion of PIP 2 to PIP 3 , and vice versa, is controlled by 2 enzymes, PI3K and PTEN, respectively. Following mass-action kinetics, where one describes the system in terms of its elementary reactions, the system can be represented as follows:
where the enzyme binds (reversibly) to the substrate, producing an enzyme-substrate complex, and then the product and enzyme are released from this complex. Converting such a representation to a set of ordinary differential equations leads to a relatively complex model with six reaction rate parameters to measure or infer, as well as the added enzyme-substrate species. Given that we only had data for a limited number of components and conditions, we would not be able to determine any of these parameters in any meaningful way. One way to simplify these reactions is to use MichaelisMenten kinetics, which makes the assumption that the enzymesubstrate complex and its reactants are in a steady state; such an assumption reduces the number of parameters that need to be measured or inferred, and simplifies the model as there is no variable needed to describe the enzyme-substrate complex:
where the reaction rates are:
It should be pointed out that, although Michaelis-Menten kinetics describe in vitro assays that measure enzyme kinetics accurately, the assumptions do not necessarily apply to in vivo conditions. 10 Using Michaelis-Menten kinetics requires 2 parameters for each enzymatic reaction (k cat and K m ), which, given that the parameter estimates were largely unconstrained (i.e., they were not restricted to a narrow range of values), would likely make such parameters unidentifiable given our data. For this reason, the reactions were reduced so that the conversion from substrate to product depended linearly on the substrate and was controlled by a single rate parameter, that is, assuming that the amount of the substrate is much smaller than the corresponding K m (PIP 2 << K m_f and PIP 3 << K m_r ). Then, defining k f = k cat_f /K m_f and k r = k cat_r /K m_r , the reaction rates become:
Using one of the principles of mass-action kinetics, where the rate of change in the concentration of the products of these reactions is proportional to the reactants' concentrations, the representations above can be converted to a system of ordinary differential equations: The mechanism of the short-term fluctuations in the single-cell traces for iSH2 and PH Akt was examined using Granger causality. For each time point t for PH Akt , the previous n points were taken for iSH2 and tested if they had any explanatory power for PH Akt . This was performed for all times t up to the addition of FK506. The iSH2 trace was then randomized in short sections, which conserved the overall dynamics of the trace but randomized the short-term variation (red trace). The Granger causality was then compared between the randomized and real iSH2 traces across all single-cells. The example shown here is replicate 1, cell 1 from experiment 1. (B) A comparison of the Granger causality between true and randomized iSH2 traces in explaining PH Akt . There was no significant difference between true and random (t = À0.61, p = 0.55, n = 14).
Any model is a simplification of the underlying biology and the above equations are based on a number of assumptions besides the aforementioned simplification of the kinetics:
1. We assumed that the PH Akt traces were representative of PIP 3 at the plasma membrane. Endogenous PIP 3 also binds to PH Akt . However, endogenous levels are notoriously low in resting cells, significantly below the k d of the PH domain to PIP 3 . Hence, the assumption was that (i) the PIP 3 molecules binding to PH Akt were those newly anabolised by the introduced iSH2, and that (ii) PIP 3 À PH Akt binding occurs on a much faster time scale compared to the change in dynamics of PIP 3 caused by the presence of iSH2 at the plasma membrane (so the rate parameter for PIP 3 À PH Akt could be ignored).
2. We assumed that, on addition of the competitive ligand FK506, the release of PH Akt from the plasma membrane was caused by PTEN activity converting PIP 3 to PIP 2 . This assumption was supported by showing that PIP 3 degradation was not affected by changes in FK506 concentration above 0.1 lM (Fig. 2D from Ref.
13).
3. We assumed that the principles of mass-action kinetics (a 3D, well-mixed environment) apply at the plasma membrane, where these reactions take place (see Section 4). 4 . We assumed that, over the time-frame of the experiment, the individual reactions are irreversible.
5. The PTEN concentration (see below for how PI3K is treated in the model) is constant and the total phosphoinositide concentration (PIP 2 + PIP 3 ) is conserved.
Both of the initial models were based on the above assumptions but differed in how active PI3K was included in the model. The activation of PI3K during chemical dimerization involves a number of steps, that is, the binding of rCD1 to iSH2, its translocation to the plasma membrane and also the activation of the catalytic subunit p110a by this complex. In modeling, there is always a trade-off between the scope of the model and the quantity of data available to validate the model. In this case, the experimental design is most suited to understanding the mechanism of PTEN activity (in terms of defining its catalytic parameters) and less well designed to defining PI3K activity, due to the number of reactions whose parameters can only be estimated by a single (iSH2) trace. There is more information available about PTEN kinetics in this experimental design as FK506 addition deactivates PI3K, leaving PH Akt dynamics to be mainly influenced by PTEN. H 2 O 2 is a PTEN inhibitor. The change in PH Akt dynamics after H 2 O 2 addition demonstrates that a phosphatase (and not, i.e., a kinase) is responsible for PIP 3 metabolism. Hence, we decided to test 2 approaches that combined the steps that lead to PI3K activation and hence make the models more tractable:
(i) Model A (see Fig. 4 ) tested the hypothesis that iSH2 becomes saturated at the plasma membrane as iSH2 is in excess of p110a (see Fig. 4) . Unfortunately, such a model precludes using the iSH2 experimental traces for validation as the quantity of iSH2 is equal to two terms in the model-free iSH2 and iSH2 bound to p110a (or active PI3K). In this model active PI3K is not constant and the following equation is added to the system:
(ii) Model B in Figure 4 represents the scaled trace of iSH2 as an explicit term in the model such that:
Hence, the iSH2 scaled trace was explicitly included in Model B for a number of reasons: (1) the experimental design would provide the most information about the mechanism behind the dynamics of PIP 3 deactivation, and hence PTEN activity, and not a mechanism of PI3K activation and (2) we wanted to test the assumption that the quantity of iSH2 at the plasma membrane was linearly proportional to the quantity of catalytically active PI3K. Such a formulation presumes that p110a, the catalytic subunit of PI3K that iSH2 binds to, is not limited at the plasma membrane and the kinetics of iSH2/p110a binding does not introduce non-linearity.
To compare models A and B, we tested how well both fitted the PH Akt data, which is represented by 'PIP 3 ' in both models. There are a number of ways of formally comparing models. In general, one wants to fit the data as well as possible while also producing a model as parsimonious as possible. The Akaike information criterion (AIC) 1 For both measures, Model A gives a lower score, which suggests this model is a better fit to the data. Indeed, visualizing the fit across all single cells (Supplementary part 4) , supports the choice of Model A over B.
Another criterion that can be used in this context is the Bayes factor, which, for 2 compared models, is the ratio of the overlap between the likelihood and prior for each model. The Bayes factor can be advantageous to use as it takes into account parameter uncertainty and can aid in model selection in the case where the 2 models have similar likelihoods (i.e., they fit the data equally well 12 ), and are similarly complex (and hence AIC/BIC cannot distinguish between them). However, it requires complex computations, and hence its calculation is computationally very expensive and prone to errors. In this case, due to the large difference in likelihoods (or fit) between Models A and B, it was unnecessary to calculate the Bayes factor as Model A was clearly a better description of the data, on average, across the single cells, as summarized by the AIC and BIC criteria. Importantly, quantitative parameter values were not tested at this point as the goal of this model comparison was to find a model structure (or structures) that could feasibly explain the data. Hence, the PH Akt traces were scaled between 0 and 1 across all experiments and the initial conditions (both quantities and kinetic parameters) were set to arbitrary values. Such dimensionless modeling comes with the assumption that (a) the model will behave similarly despite the change in the difference of orders of magnitude among the variables and (b) the MCMC algorithm finds the optimum parameters for each candidate model. We return to (a) in the discussion below and (b) was verified by testing for convergence of the posterior probabilities of the model parameters (Supplementary part 5) .
Prior to considering parameter identifiability, comparing the likelihoods of each model explaining the single cell traces of PH Akt favors the saturation model over that of iSH2 having a linear relationship with active PI3K.
Testing for covariance and parameter identifiability
As well as providing an estimate of the parameters that best fit the data, Bayesian inference also gives information about parameter identifiability and uncertainty through the probability distributions of the parameters. Figure 5 shows the probability distributions across the 14 single cell measurements for the PTEN rate parameter (k r ), when trained against experiment 1 alone. It is clear that the experimental design is well suited to obtaining accurate measurements of this parameter. The mean standard deviation across all cells is 0.0004 A À1 s À1 (excluding the outlier replicate 3, cell 7) with a mean of 0.022 A À1 s À1 (where A represents the arbitrary unit of concentration in the model). In Model A, after the addition of the competitive dimerizer FK506, it is assumed that PI3K is deactivated immediately. Hence, the rate of PIP 3 loss from the plasma membrane, represented by the PH Akt trace, is controlled solely by the rate of PTEN catalysis and this parameter can be estimated with high confidence. As well as the probability distributions of k r , Figure 5 also shows the k r value (red line) that produced the best fit to the data for each single cell. This is not necessarily the same as the mean of the distribution, as one would expect. The reason for this is that the red line is the peak of the joint probability distribution across all estimated parameters, which is not necessarily the same as the single (or marginal) distribution for a single parameter (see Table 1 ). Figure 5 . The probability distributions for the PTEN rate parameter (k r ) across the 14 single-cell traces. The red line shows the value of k r that produced the best fit to the data. Interestingly, despite the experimental design's suitability to estimating the PTEN rate parameter, the PI3K (k f ) and PTEN (k r ) parameters show strong linear covariation (Fig. 6 , mean Pearson's correlation = 0.84, n = 14), albeit over a narrow range for both k f and k r . This is a consequence of the linked nature between the forward and reverse reactions in Model A; even though k r is strongly constrained by the removal of active PI3K by FK506, within this range it is only possible to infer the ratio of k f and k r , that is, of the forward and reverse reactions.
The added information from the H 2 O 2 experiment (experiment 2)
For the next step, we tested what information could be gained from experiment 2: the addition of H 2 O 2 to inhibit PTEN. For each PH Akt trace in experiment 1 (n = 14), we trained the reaction rate parameters in Model A to both the data from experiment 1 and experiment 2 combined. In order to do this, the PH Akt traces from experiments 1 and 2 needed to be paired. This was done by taking the closest steady state values from the distributions (as shown in Fig. 2 , see also Supplementary part 1) between the 2 experiments. Figure 7 shows that the added experiment further constrained the PI3K rate parameter k f (experiment 1 mean standard deviation (SD) 3.6 e À5 ; experiment 1 and 2 mean SD 9.1 e À6 ; n = 14) and also changed the mean estimate across all single cells of k f (t = 2.1, p = 0.04, n = 14). Figure 8 shows the fit of Model A trained to experiment 1/2 combined against the data from experiment 2. Hence, from Figure 7 , one can quantify, in terms of the change in the k f probability distributions from 'experiment 1' to 'experiment 1/2', the added information that is gained from experiment 2.
Discussion
In this paper, we have illustrated the value of mathematical models to study biochemical processes in general, and PIP 3 regulation in particular. We have discussed key aspects to keep in mind when building models, such as the level of granularity and scope of the model and the need for appropriate normalization. We have . The black line with the grey border represents the mean ± the standard deviation of the simulation of PIP 3 using Model A fitted to the data from experiments 1 and 2 combined (n = 14, the fit to experiment 1 is show in Supplementary Fig. S8 ). The red line with error bars represents the mean ± the standard deviation of experiment 2 for all single-cell traces (n = 17). As noted, the measurements from experiment 2 commenced 27.5 min after rCD1 additions, whereas the model is simulated from t = 0. The downwards spike in the experimental traces is an experimental artifact.
listed all assumptions that went into building our model; these assumptions have to always be kept in mind as they may be violated in the experiments the model is based on, hence affecting potentially the conclusions made. The insight that a model can provide is largely determined by the experimental data used to build it. As illustrated here, the ability of chemical dimerizers and their competing ligands to rapidly activate and deactivate enzymes makes the technology an important tool in modeling signaling pathways. By simulating PIP 3 dynamics using a simple model incorporating PI3K and PTEN, we have shown that such an experiment can help identify the kinetics of enzymes and decrease uncertainty in their estimation. However, it is also clear that identifiability of parameter values is also highly dependent on the model structure and the assumptions underlying the model. For the model comparison and exploration above, arbitrary units were used for the concentrations of the model species. Despite the limitations in terms of quantitative insight, such dimensionless models are useful tools. Importantly, dimensionless models require much less information and can be built without quantitative data. Some biological information could be included with this approach; in the model the quantity of PIP 2 was an order of magnitude greater than the maximum amount of PIP 3 across all cells and hence the quantity PIP 2 + PIP 3 was kept constant.
In order to provide the parameters dimension, thereby making them biologically interpretable, two problems must be solved:
1. The model must be adapted to take account of the two-dimensional environment at the plasma membrane where these reactions take place: As explained above, mass-action and Michaelis-Menten kinetics assume the reactions take place in a homogenous well-mixed environment. However, phospholipids (PIP 2 and PIP 3 ) and their regulating enzymes (PI3K and PTEN, among others) interact at the plasma membrane, which greatly increases the rate of interaction between the molecules. One way to reflect this in a model is to introduce a scaling factor that is the plasma membrane area to cell volume ratio. 31 More complicated biophysical models can also be used that explicitly include factors such as diffusion and electrostatic forces. 20 One of the challenges of modeling signaling pathways is judging the importance of including such additional parameters and whether models such as these can be connected to mass-action models of signaling (i.e., multi-scale modeling 11 ).
2. Secondly, the initial concentrations/amounts of the model species must be found. For plasma membrane-bound models such as phosphoinositides (PIP 2 and PIP 3 ), it is most accurate to use units such as 'number of molecules'/lm 2 . Although such estimates can be found from literature, it is more difficult defining the amount of PI3K at the plasma membrane. Total cell concentrations of PI3K have been estimated 13 but this total includes cytoplasmic and plasma membrane-bound populations.
Regarding the model itself, it has been shown that the mechanisms controlling PI3K activity are much more complex than represented here. 29 However, the simple model was able to fit the data well. This suggests that the more complex feedback mechanisms that regulate PI3K were either not active during the timeframe of the experiments in this study, or perhaps any additional mechanisms were masked by the stronger kinetics of the forward/reverse reactions controlled by PI3K/PTEN. In either case, further experiments would be needed to build a more complex model that would allow for understanding additional PI3K regulation. A similar approach to the one taken in this study was performed by Bandara et al. 5 They also used a chemical dimerization system to infer the parameters of PIP 3 metabolism. The main difference is that, instead of the competitive dimerizer FK506 to deactivate PI3K, they used a small molecule inhibitor. The consequence of this is that active PI3K could not be inhibited as quickly as when using FK506. This necessitated the use of extra parameters in their model to explain active PI3K inhibition although, in comparison, they explored additional experiments to constrain these parameters. The goal of their study was to optimally design an experiment based on the timing and concentration of inhibition that would reduce uncertainty in the parameter estimations. To quantify the uncertainty of their parameter estimates, instead of calculating the probability distributions as here, they performed sensitivity analysis. This defined the uncertainty of a parameter as inversely proportional to the sensitivity of the model prediction to changes in the parameter value. Hence, both their approach and that taken here provide a practical comparison of the advantages/disadvantages of probabilistic parameter inference, some of which we outline below. Bayesian approaches have a much larger computational cost for calculating probability distributions when estimating model parameters from data, which limits the size of the models that can be applied. In addition, Bayesian parameter inference is more complex in nature and requires more expertise. However, such approaches to parameter inference provide a sound framework to deal with parameter uncertainty. Cellular signaling pathways have been well-studied for the past 30 years and a large amount of information has accumulated. 19 Such information includes signaling interactions, binding affinity estimates from multiple in vitro studies and concentration estimates of pathway constituents (small molecules, proteins, lipids, etc.) This information can be included in Bayesian parameter inference in the form of a prior distribution, or one's belief in the distribution of the parameter. As mentioned above, model comparison in the form of the Bayes factor, is an additional advantage of Bayesian inference, especially in the case where the competing models have similar fits and complexity. 12 Additionally, Bayesian inference allows for direct examination of covariance in the data by examining joint distributions between pairs of parameters in a model. This can formally identify regions of the model where identifying the true parameter values is difficult, or impossible given the experimental data (e.g., the on/off rates of two molecules binding).
